TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 1nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 550nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 305nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 550nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 283nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 2nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 5nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 12nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 2nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 2nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 2nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 1nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair